Industry Short Snapper Session - Part 2

Back to the Future of IBD

Learning Objectives:

Better understand the comparative efficacy of the IV vs. SC formulations of infliximab
Be more confident using SC infliximab as monotherapy
Be better able to predict long term efficacy and persistence in their patient population

Speaker:

Dr. Jason Reinglas MD. FRCPC

Dr. Jason Reinglas is a gastroenterologist and Director of the Scarborough Center for Inflammatory Bowel Disease. Dr. Reinglas completed his MD degree as well as his Internal Medicine and Gastroenterology residencies at the University of Ottawa. Dr. Reinglas then completed an advanced IBD fellowship in Montreal at McGill University.

Back to Main Website Close X